BioSpace News Archive

Biotech Bay

HelloMD Extends HIPAA Compliant Video Chats, Between Cannabis Patients and Doctors, to all 50 States

Having connected more than 100,000 cannabis patients to doctors and nurse practitioners in California, New York, and Canada via online video, HelloMD now says “Hello!” to canna-curious patients nationwide.

March 6, 2019
·
3 min read
Deals

Epizyme Announces Pricing of Concurrent Public Offerings of Common Stock and Series A Preferred Stock - March 7, 2019

Epizyme, Inc. today announced the pricing of two concurrent underwritten public offerings of (i) 10,000,000 shares of its common stock and (ii) 304,348 shares of its non-voting Series A Convertible Preferred Stock.

March 6, 2019
·
5 min read
BioMidwest

Market Scope Reports Global Demand for Spine Surgery Grows With Access to Care

Global demand for spine surgery is expected to rise at a compound annual growth rate of 9.7 percent from 2018 to 2023, with annual volume increasing from 3.6 million to 4.3 million procedures.

March 6, 2019
·
2 min read
Drug Development

SanBio to Announce the Results of a Phase 2 STEMTRA Trial Regarding the Use of Regenerative Cell Medicine SB623 as a Treatment for TBI at an Annual Scientific Meeting of the American Association of Neurological Surgeons

The SanBio Group today announced its plan to make public the results of a global Phase 2 trial (Study of Modified Stem Cells in Traumatic Brain Injury, or “STEMTRA”) conducted in the US and Japan regarding the use of regenerative cell medicine SB623 as a treatment for chronic motor deficit from traumatic brain injury (TBI).

March 6, 2019
·
2 min read